Researchers from the University of Nottingham have discovered a new method to target and destroy cancer cells in difficult-to-treat brain tumors. They used electrically charged molecules to trigger self-destruction in the cancer cells. This breakthrough could potentially be developed into a spray treatment used during surgery.
The team focused on patient-derived glioblastoma cells, a type of brain cancer that is hard to treat. The survival rate for glioblastoma is extremely low, with an average life expectancy of only 8 months after diagnosis. The researchers found that their technique could specifically target glioblastoma cells while leaving healthy cells unharmed, offering a level of precision never seen before.
This opens up new possibilities for treating glioblastoma during surgical removal of the tumor. The electrically charged molecules, called bio-nanoantennae, could be sprayed or injected at the site of the tumor. The researchers believe that this is the first “quantum therapeutic” that taps into the potential of quantum signaling to combat cancer.
The team has already secured funding and filed a patent to begin translating the technology into clinical use. However, further research and validation are necessary to ensure the safety and effectiveness of the bio-nanoantennae for human use.
This breakthrough is particularly significant for glioblastoma treatment, as current options are limited and prognosis for patients is poor. The researchers believe that quantum therapeutics could revolutionize the treatment of diseases, bringing us closer to a new treatment paradigm.
>Source link>
>>Join our Facebook Group be part of community. <<